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INTRODUCTION
In children and adolescents, syncope is a common problem.
It has been reported that children with orthostatic positive
neurocardiogenic syncope showed a different QT response to
beta-adrenergic stimulation of isoproterenol (1). Autonomic
dysfunction has been postulated as a possible underlying mech-
anism for syncopal episodes; cardiac and peripheral vascular
autonomic control appeared to play a role (2-4).
Among the children who presented with syncope or presyn-
cope, some showed ventricular arrhythmia on surface electro-
cardiogram or 24 Holter monitoring without positive find-
ings on head-up tilt test. In those cases, it is important to
define whether ventricular arrhythmias can become malignant
and play a crucial role in the genesis of syncope or whether
these ventricular arrhythmias are incidental findings. The vari-
ations in QT interval duration have been advocated as a mark-
er of arrhythmogenicity, which is based on the evidence that
increased heterogeneity of repolarization provides a substrate
for malignant ventricular arrhythmias (5, 6). Therefore, the
assessment of QT interval may help us predict the risk of ven-
tricular arrhythmia.
In this study, we investigated the effect of beta-adrenergic
stimulation on the heart rate and QT interval in children with
syncope or presyncope. The purpose of this study was to exam-
ine whether there are different changes in response to isopro-
terenol between syncopal children with and without ventric-
ular arrhythmias.
MATERIALS AND METHODS
After excluding the patients with a typical history of neu-
rally mediated syncope or presyncope with positive head-up
tilt test, 24 patients were enrolled in this study. The study was
done primarily to evaluate the cause of syncope or presyncope.
In all of these children, structural cardiac abnormalities were
excluded by physical examination and noninvasive studies in-
cluding echocardiography. The analyses of electrocardiograms
at the basal state and during the provocative state with isopro-
terenol were performed to define the electrophysiological clues
to the ventricular arrhythmia or syncope. Based on the pres-
ence of ventricular arrhythmias on ECG or 24-hr Holter mon-
itoring, 13 children with ventricular arrhythmias were clas-
sified into the ventricular arrhythmia (VA) group, and the re-
maining 11 without ventricular arrhythmias into the syncope
only (Syn) group. The VA group included children with sig-
nificant ventricular arrhythmias (frequent monomorphic ven-
tricular extrasystole; polymorphic ventricular arrhythmia; not
suppressible during exercise test) and with a vague history of
neurally mediated syncope. The Syn group included children
with a vague history of neurally mediated syncope and with
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The Effect of beta Adrenergic Stimulation on QT and QTc Interval in
Syncope Children with or without Coexisting Ventricular Arrhythmias
We investigated the effect of beta-adrenergic stimulation on the heart rate and QT
interval in syncope children with or without coexisting ventricular arrhythmias (VA).
Of the 24 children who presented with syncope or presyncope and showed nega-
tive tilt test, 13 were classified into a group with VA and the remaining 11 without
VA. The provocative test was performed in bolus infusion and continuous infusion.
RR, QT, and QTc intervals on routine 12-lead surface electrocardiogram were
obtained during each stage of isoproterenol infusion. In all cases, malignant ven-
tricular arrhythmia and syncope were not induced by isoproterenol provocative test.
RR and QT intervals were shortened and QTc intervals were prolonged as the iso-
proterenol dose was increased in both groups and methods. The QTc interval re-
ached its peak level after the bolus injection of 1.0  g and during the continuous
infusion of 0.03  g/kg/min. The two groups showed no significant difference in the
QTc interval change according to the infusion methods. This study indicates that
changes in the heart rate and QT interval by beta-adrenergic stimulation were not
different according to the coexisting ventricular arrhythmias in syncope children
with negative head-up tilt test.
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negative head up tilt test. The average age of the study sub-
jects at the time of the study was 127 months (range 41-197
months). They consisted of 15 males and 9 females. 
The VA group consisted of 8 males and 5 females with an
average age of 99±37 months (range, 41-161 months). Poly-
morphic ventricular extrasystole was noted in 3 cases and non-
sustained monomorphic ventricular tachycardia in 2 cases. The
Syn group consisted of 7 males and 4 females with an aver-
age age of 157±34 months (range, 82-196 months). Each
subject did not have any evidence of congenital long QT syn-
drome or TU complex abnormalities. In all of these children,
head-up tilt test was performed without inducing syncope or
near syncope during the test. 
We analyzed 12-lead electrocardiograms (ECG), which
were obtained at the basal resting period and during the infu-
sion of isoproterenol. The provocative test started with a bolus
infusion of isoproterenol at a dose of 0.25  g; the isoproterenol
dose was increased to 0.5  g and then to 1.0  g five minutes
after the preceding bolus infusion. ECG was recorded at 30
sec, 60 sec, 90 sec, 2 min, 3 min, and 5 min after each bolus
infusion. The continuous infusion of isoproterenol was done
20 min after the completion of the bolus test. The test was
performed at a dose of 0.01  g/kg/min for 5 min, and then
the dose was increased up to 0.04  g/kg/min by an incre-
ment of 0.01  g while obtaining the ECG at 30 sec, 60 sec,
90 sec, 2 min, 3 min, and 5 min. In all cases, malignant
ventricular arrhythmia or syncope was not induced by iso-
proterenol provocative test.
The standard 12-lead ECG recordings were obtained at a
paper speed of 50 mm/sec and a scale of 1 mV/10 mm. QT
interval was measured from the lead II using calipers when
the RR interval was maximally shortened at each stage of iso-
proterenol infusion. The measurements of QT were taken and
averaged from at least three consecutive beats after each dose
of isoproterenol at the point corresponding to the maximum
heart rate effect. QT interval was defined as the interval be-
tween the beginning of QRS complex and the end of the T
wave. The offset of the T wave was defined as the intersections
of the isoelectric line and the tangent of the maximal slope on
the down limbs of the T wave. Bazett’s formula was used to
obtain corrected QT intervals. 
The data are expressed as mean plus standard deviation.
The data were analyzed using the analysis of variance (ANO-
VA) for repeated measures. A value of  p<0.05 was considered
the limit for significance. 
RESULTS
RR interval
The heart rate (RR interval) reached its peak level at 60-90
sec after bolus infusion and at 3-5 min during continuous
infusion of isoproterenol (Fig. 1)
The baseline RR interval was 693±138 msec (range,
500-960 msec) in the VA group and 774±157 msec (range,
570-1,020 msec) in the Syn group.
At the bolus infusion of isoproterenol, the RR interval was
shortened as the dose increased; 574±117, 543±110, and
496±106 msec at 0.25, 0.5, and 1.0  g in the VA group
and 639±103, 628±110, and 579±97 msec, respective-
ly, in the Syn group. 
During the continuous infusion, the RR interval was short-
ened; 574±90, 513±80, 480±63, and 436±54 msec at
0.01, 0.02, 0.03, and 0.04  g/kg/min in the VA group and
640±119, 566±111, 515±84, and 460±60 msec, respec-
tively, in the Syn group.
The RR intervals in the VA group were shorter than those
in the Syn group, although the difference was statistically
insignificant at any dose including the baseline. The RR
intervals were shortened as the isoproterenol dose increased
in both groups and methods. In bolus infusion, the first dose
made a greater change in RR interval than the later doses. Dur-
ing continuous infusion, the amount of decrement of RR inter-
val in continuous infusion decreased gradually. When the data
from the two groups were compared, there was no significant
difference in the change of RR interval in either methods of
isoproterenol infusion.
QT interval 
The baseline QT interval was 348±37 msec (range, 280-
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Fig. 1. The RR intervals in the VA group were shorter than those in
the Syn group (p>0.05). The RR intervals are shortened as the
isoproterenol dose is increased in both groups and methods
(p<0.05). In bolus infusion, the first dose makes a greater change
than the later doses (p<0.05). The two groups show no significant
difference. VA, ventricular arrhythmia group; Syn, syncope only
group; bolus, bolus infusion; cont, continuous infusion.
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420 msec) in the VA group and 370±28 msec (range, 320-
400 msec) in the Syn group. QT intervals were measured after
each dose of isoproterenol at the point corresponding to the
maximum heart rate effect, that is, at the shortest RR inter-
vals after each dose (Fig. 2).
After the bolus infusion of isoproterenol, the QT interval
was shortened with the increase of dose; 335±46, 334±43,
and 327±46 msec at 0.25, 0.5, 1.0  g in the VA group, 363
±23, 361±22, and 361±21 msec, respectively, in the
Syn group. 
During the continuous infusion, the QT interval was short-
ened gradually according to the increasing dose of isopro-
terenol in both groups; 340±33, 327±39, 317±38, 298
±33 msec at 0.01, 0.02, 0.03, and 0.04  g/kg/min in the
VA group and 363±28, 349±27, 335±31, and 314±
29 msec, respectively, in the Syn group. 
The QT interval was shortened significantly in response to
the increase of isoproterenol in both methods. However, the
changes of QT interval after isoproterenol infusion were some-
what different by the method of infusion. Similar to the RR
interval change after the bolus infusion, a greater or greatest
change of QT interval appeared at the initial dose but the
change was somewhat smaller at the later doses. The change
of QT interval during continuous infusion showed a steeper
decrease than in bolus infusion. The QT interval in the Syn
group was longer than in the VA group by both methods
(p<0.05). However, when the data from the two groups were
compared, there was no significant difference in the change
of QT interval in either methods of isoproterenol infusion.
QTc interval  
The baseline QTc interval in the VA group was 420±27
msec (range, 396-429), and 423±33 msec (range, 396-
462 msec) in the Syn group. QTc intervals were calculated
using the Bazett’s formula (Fig. 3).
At the bolus infusion of isoproterenol, the QTc interval was
prolonged with the increase of dose; 444±27, 456±29, 467
±33 msec at 0.25, 0.5, 1.0  g in the VA group and 458±
36, 460±36, and 479±35 msec, respectively, in the Syn
group. 
During the continuous infusion, the QTc interval was
lengthened; 449±15, 456±27, 457±34, and 451±26
msec at 0.01, 0.02, 0.03, and 0.04  g/kg/min in the VA
group and 458±30, 467±32, 469±27, and 464±24
msec, respectively, in the Syn group.
The QTc interval was prolonged significantly as the dose
of isoproterenol increased in both methods. In the bolus infu-
sion, the QTc interval reached its peak level at the highest
bolus dose of 1.0  g and at a dose of 0.03  g/kg/min of con-
tinuous infusion. In each stage of the two methods, there was
no significant difference in the change of QTc interval be-
tween VA and Syn groups.
Q
T
 
i
n
t
e
r
v
a
l
 
(
m
s
e
c
)
380
360
340
320
300
280
260
baseline 1st 2nd 3rd 4th
VA bolus
VA cont
Syn bolus
Syn cont
Fig. 2. The effect of isoproterenol on QT intervals. The QT interval
is shortened gradually according to the increasing dose of iso-
proterenol in both groups and methods. The change of QT inter-
val during continuous infusion shows a steeper decrease than in
bolus infusion. The QT interval in the Syn group is longer than in
the VA group by both methods (p<0.05). There is no significant
difference in the change of RR interval in either methods of iso-
proterenol infusion between two groups (p>0.05). VA, ventricular
arrhythmia group; Syn, syncope only group; bolus, bolus infusion;
cont, continuous infusion.
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Fig. 3. The QTc interval is prolonged significantly as the dose in-
creased in both methods (p<0.05). QTc interval reaches its peak
level at the bolus dose of 1.0  g and at the continuous dose of 0.03
( g/kg/min. The two groups show no significant difference in the
change of QTc interval. VA, ventricular arrhythmia group; Syn, syn-
cope only group; bolus, bolus infusion; cont, continuous infusion.   
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DISCUSSION 
In this study, isoproterenol accelerated the heart rate, short-
ened the QT interval, and prolonged the QTc interval in both
groups of the children. However, there was no significant
difference in the change of RR and QT intervals whether
ventricular arrhythmia was associated or not.     
Children with neurocardiogenic syncope, proven by a pos-
itive head-up tilt test, have been shown to have beta-adren-
ergic hypersensitivity (2). Children with orthostatic positive
neurocardiogenic syncope showed a significantly larger QT
interval increment than the negative group after bolus injec-
tion of isoproterenol (1, 4). This supports the theory that al-
tered beta-adrenergic sensitivity exists in children with neu-
rocardiogenic syncope. In syncope patients who showed neg-
ative findings on head-up tilt test, QT interval was report-
edly not prolonged by beta stimulation, and autonomic dys-
function such as beta-adrenergic hypersensitivity may not
play a major role in syncope (1). Our results showed insignif-
icant changes of QT interval in children with tilt negative
syncope. Even though we did not compare the QT interval
change between the tilt-positive and tilt-negative groups and
thus cannot ascribe the syncope in these children to neuro-
cardiogenic syncope, our results seemed to be concordant
with previous reports. 
If a child with complex ventricular arrhythmia or ventric-
ular arrhythmia not suppressible during exercise suffers from
syncope, it is very likely that ventricular arrhythmia is regard-
ed as a cause of syncope particularly if the result of head-up
tilt test is negative. We proposed that ventricular arrhyth-
mia might be due to repolarization abnormality if related to
syncopal episode, and isoproterenol could provoke the covert
repolarization abnormality. We found that in some children,
the later part of the TU complex became prominent after
the infusion of isoproterenol without TU prolongation and
was associated with ventricular arrhythmia. This finding
might imply increased after-depolarization by isoproterenol.
However, it needs further investigation. 
Developmental imbalance in cardiac sympathetic innerva-
tion may predispose to ventricular fibrillation and may be as-
sociated with temporary prolongation of the QT interval (7).
It is very important to understand the response of repolariza-
tion to sympathetic stimulation in children, which could be
helpful for preventing life-threatening events caused by ven-
tricular arrhythmias. Since the hearts of children continue to
develop to maturity, we should not apply data from adults to
children. In children, however, few data are available on the
change of ventricular repolarization induced by beta-adrenergic
stimulation (1, 2, 8, 9).
Assessment of repolarization change may help us predict
the risk of ventricular arrhythmia and to guess the mechanism
of syncope induced by ventricular arrhythmia. Beta-adren-
ergic stimulation increases the heart rate and shortens the QT
interval in normal people (10). Abildskov showed in dogs that
isoproterenol prolonged the QT interval when given as a
bolus, but shortened it when given by continuous infusion
(11). However, our results demonstrated a similar effect on
QT interval when isoproterenol was given by bolus injection
or continuous infusion. This may indicate that there are dif-
ferences between species (human and dog) and/or specific dis-
eases. Further study with isoproterenol is needed to elucidate
the underlying mechanism.
Previous reports on the effect of alterations of the heart rate
on the QT interval in adults have shown conflicting results
(12, 13). In children and adolescents, the heart rate directly
influences QT and QTc intervals on beta-adrenergic stimu-
lation and atrial pacing. The QT is shortened, but QTc is
prolonged. Reliance on the QTc alone could lead to an erro-
neous diagnosis of long QT syndrome. After beta-adrener-
gic stimulation, there is a far greater change in the denomi-
nator (RR) than in the numerator (QT) if one uses the Bazett’s
formula, and this leads to overcorrection that produces a spu-
riously high value. This could potentially lead to a false diag-
nosis of abnormal QT syndrome in these patients (14). In this
study, because the mean age at the time of the study in the
VA group was younger than that in the syncope only (Syn)
group (p<0.05), RR and QT intervals in the VA group were
shorter than in the Syn group (p<0.05). The continuous infu-
sion of isoproterenol was found to be more effective than the
bolus infusion in increasing the heart rate and QT interval.
In the continuous infusion of isoproterenol, whereas RR and
QT intervals continued to get shorter inversely with the
increase of the isoproterenol dose, the QTc interval reached
its peak level at the dose of 0.03  g/kg/min. These data prob-
ably have resulted from the overcorrection using the Bazett’s
formula. In bolus infusion, the heart rate and QT interval
changed less effectively on the second and third doses. But
the QTc curve showed an increasing pattern according to the
dose increment of isoproterenol because the change of RR
interval (denominator) had some greater interval change than
the QT interval (numerator). The two groups (VA and Syn)
showed no significant difference in response to isoproterenol
in either methods. However, the two methods of infusion of
isoproterenol showed a different pattern. Because the dose
of isoproterenol in bolus infusion is not based on the body
weight, the effective drug level may not be achieved. Also
the fluctuation of drug concentration in serum may contribute
to the different patterns in both infusion methods. The ven-
tricular muscle may need persistent and prolonged level of
stimulation in order to change the repolarization homogene-
ity. This may suggest that ventricular repolarization inhomo-
geneity could be disclosed when enough dose of beta-adren-
ergic stimulation is given to a child with a normal heart. In
children with normal heart, ventricular arrhythmia may not
be associated with ventricular inhomogeneity unlike myocar-
dial infarction. Although the abnormal QT interval change
was not induced by beta stimulation, ventricular inhomo-
geneity and/or autonomic dysfunction may not be excludedQT Interval in Syncope Children  183
in the arrhythmogenesis. 
In conclusion, beta-adrenergic stimulation may not be
helpful for investigating the etiologic mechanism in syncope
children who have negative tilt test with or without coexist-
ing ventricular arrhythmia. Autonomic dysfunction and ven-
tricular repolarization inhomogeneity are less likely to be in-
volved in genesis of syncope. 
REFERENCES
1. Balaji S, Oslizlok PC, MckayCA, Allen MC, Case CL, Hewett KW,
Gillette PC. Effect of beta-adrenergic stimulation on the QT interval
of children with syncope. Pacing Chin Electrophysiol 1994; 17:
152-6.
2. Perry JC, Garson A Jr. The child with recurrent syncope: autonomic
testing and beta-adrenergic hypersensitivity. J Am Coll Cardiol
1991; 17: 1168-71.
3. Struthers AD, Reid JL, Whitesmith R, Rodger JC. The effect of car-
dioselective and non-selective beta-adrenoceptor blockade on the
hypokalemic and cardiovascular responses to adrenomedullary hor-
mones in man. Clin Sci (Lond) 1983; 65: 143-7.
4. Glickstein JS, Schwartzman D, Friedman D, Rutkowski M, Axelrod
FB. Abnormalities of the corrected QT interval in familial dysautono-
mia: an indicator of autonomic dysfunction. J Pediatr 1993; 122: 925-8.
5. Surawicz B. Will QT dispersion play a role in clinical decision mak-
ing? J Cardiovasc Electorphysiol 1996; 7: 777-84.
6. Day CP, McComb JM, Campbell RW. QT dispersion in sinus beats
and ventricular extrasystole in normal hearts. Br Heart J 1992; 67:
39-41.
7. Schwartz PJ. Cardiac sympathetic innervation and the sudden infant
death syndrome. A possible pathogenetic link. Am J Med 1976; 60:
167.
8. Noh CI, Gillette PC, Case CL, Zeigler VL. Clinical and electrophysio-
logical characteristics of venricular tachycardia in children with
normal hearts. Am Heart J 1990; 120: 1326-33.
9. Leenhardt A, Lucet V, Denjou I, Grau F, Ngoc DD, Coumel P. Cate-
cholaminergic polymorphic ventricular tachycardia in children; a 7-
year follow-up of 21 patients. Circulation 1995; 91: 1512-9.
10. Davidowski TA, Wolf S. The QT interval during reflex cardiovas-
cular adaptation. Circulation 1984; 69: 22-5.
11. Abildskov JA. Adrenergic effects on the QT interval of the electro-
cardiogram. Am Heart J 1976; 92: 210-6.
12. Ahnve S, Vallin H. Influence of heart rate and inhibition of autonom-
ic tone on the QT interval. Circulation 1982; 65: 435-9.
13. Browne KF, Zipes DP, Heger JJ, Prystowsky EN. Influence of the
autonomic nervous system on the QT interval in man. Am J Cardiol
1982; 50: 1099-103.
14. Balaji S, Lau YR, Gillete PC. Effect of heart rate on QT interval in
children and adolescents. Heart 1997; 77: 128-9.